Faculty Disclosures
| Anthony L. Fine, MD |
The institution of Dr. Fine has received research support from Neurocrine Biosciences. The institution of Dr. Fine has received research support from American Board of Psychiatry and Neurology. |
| Temitayo Oyegbile-Chidi, MD, PhD, FAAN |
Dr. Oyegbile-Chidi has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Spectrum/The Transmitter. The institution of Dr. Oyegbile-Chidi has received research support from NIH. |
| Jordan S. Dubow, MD |
Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revalesio . |
| Sarah Glass, PhD |
Dr. Glass has received personal compensation for serving as an employee of n-Lorem Foundation . |
| samrat thouta, PhD |
Dr. thouta has received personal compensation for serving as an employee of Xenon Pharamceuticals. Dr. thouta has stock in Xenon Pharmaceuticals. |
| Jessie Lynch |
Mrs. Lynch has received personal compensation for serving as an employee of Stoke Therapeutics. Mrs. Lynch has stock in Stoke Therapeutics. |
| Mariam A. Mostafa II, MBBS |
Dr. Mostafa has nothing to disclose. |
| Lan Lan, MD |
Mrs. Lan has received personal compensation for serving as an employee of argenx. |
| Linda Ottoboni |
Linda Ottoboni has nothing to disclose. |
| María Jose Lopez, MD, PhD |
Dr. Lopez has nothing to disclose. |
| Nicholas Smith, MBBS, PhD, FRACP |
The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Forge Bio. The institution of Dr. Smith has received research support from Ultragenyx. The institution of Dr. Smith has received research support from Cyclotherapeutics. The institution of Dr. Smith has received research support from BluebirdBio. The institution of Dr. Smith has received research support from Sanfilippo Children's Foundation. The institution of Dr. Smith has received research support from Medical Research Future Fund. The institution of Dr. Smith has received research support from Women's and Children's Hospital Foundation. |
| Matthew Waldbrook |
Mr. Waldbrook has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Mr. Waldbrook has stock in Xenon Pharmaceuticals. |
| Chiara Cordiglieri, PhD |
Dr. Cordiglieri has nothing to disclose. |
| Andreas Brunklaus, MD |
Prof. Brunklaus has received personal compensation in the range of $0-$499 for serving as a Consultant for Servier. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded Therapeutics. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biocodex. Prof. Brunklaus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. |
| Abigail N. Schwaede, MD |
Dr. Schwaede has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Schwaede has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . |
| Yehia Nabil |
Yehia Nabil has nothing to disclose. |
| Giacomo Comi |
Giacomo Comi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Giacomo Comi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. |
| Kevin M. Flanigan, MD, FAAN |
Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Armatus. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne. The institution of Dr. Flanigan has received research support from Ultragenyx . The institution of Dr. Flanigan has received research support from Solid Biosciences. The institution of Dr. Flanigan has received research support from Dyne Therapeutics. The institution of Dr. Flanigan has received research support from Avidity. |
| Ahmed E. Kertam, MBBS |
Dr. Kertam has nothing to disclose. |
| Frank Bennett, PhD |
No disclosure on file
|
| Ryan Mitchell, PhD |
Dr. Mitchell has received personal compensation for serving as an employee of Satellos Bioscience. |
| Laurence Mignon, PhD |
Dr. Mignon has received personal compensation for serving as an employee of n-Lorem Foundation. Dr. Mignon has stock in Ionis Pharmaceuticals, JNJ, Nvidia.. The institution of Dr. Mignon has received research support from CIRM. |
| Olivia S. Kim Mcmanus, MD |
Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina . Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Kim Mcmanus has received research support from California Institute for Regenerative Medicine. The institution of Dr. Kim Mcmanus has received research support from National Institutes of Health/NCATS. |
| Samuel J. Goodchild, PhD |
Dr. Goodchild has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Goodchild has stock in Xenon Pharmaceuticals. |
| Delia Gagliardi, MD, PhD |
Dr. Gagliardi has nothing to disclose. |
| John M. Schreiber, MD |
Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. The institution of Dr. Schreiber has received research support from Dravet Syndrome Foundation. |
| Aima Muzaffar, MBBS |
Dr. Muzaffar has nothing to disclose. |
| Caroline Neuray |
The institution of Caroline Neuray has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clouds of Care. The institution of Caroline Neuray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Saniona. |
| Joseph Sullivan, MD |
Dr. Sullivan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Sullivan has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Study Consortium. Dr. Sullivan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropace. Dr. Sullivan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Various firms. Dr. Sullivan has stock in Harmony. |
| Nancy L. Kuntz, MD, FAAN |
Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta. |
| Celine M. Dube, PhD |
Dr. Dube has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Dube has stock in Xenon Pharmaceuticals. |
| Matteo Miotto |
Matteo Miotto has nothing to disclose. |
| Gert Vanhollebeke, PhD |
Dr. Vanhollebeke has received personal compensation for serving as an employee of Clouds of Care. |
| julie douville, PhD |
Dr. douville has nothing to disclose. |
| Heather Lau, MD |
Dr. Lau has received personal compensation for serving as an employee of Ultragenyx. Dr. Lau has or had stock in Ultragenyx. |
| James W. Wheless, MD, FAAP, FACP, FAAN, FAES, FCNS, FAAN |
Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelius. |
| Melissa Wolf, PT |
Mrs. Wolf has received personal compensation for serving as an employee of Ultragenyx Pharmaceutical. Mrs. Wolf has stock in Ultragenyx Pharmaceutical. |
| Kristen Burford |
Dr. Burford has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Burford has stock in Xenon Pharmaceuticals. Dr. Burford has received intellectual property interests from a discovery or technology relating to health care. |
| Anna Bogatyreva, MD, PhD |
Dr. Anna has received personal compensation for serving as an employee of argenx BV. |
| Tonke van Bragt, MSc |
The institution of Mrs. van Bragt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Mrs. van Bragt has stock in argenx. |
| Janelle Celso |
Mrs. Celso has nothing to disclose. |
| Ashan S. Fareed, MBBS |
Mr. Fareed has nothing to disclose. |
| J. Helen Cross |
Dr. Cross has nothing to disclose. |
| Alison Cutts |
Alison Cutts has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Alison Cutts has stock in Xenon Pharmaceuticals. Alison Cutts has received intellectual property interests from a discovery or technology relating to health care. |
| Dabbara V. Ramana |
Mr. Ramana has nothing to disclose. |
| Affan Tasleem, MBBS |
Dr. Tasleem has nothing to disclose. |
| Stefania Corti, MD, PhD |
Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Corti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. |
| Emiel Vereycken |
Mr. Vereycken has nothing to disclose. |
| Steven Petrou, FAHMS |
Dr. Petrou has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Petrou has stock in Praxis Precision Medicines. The institution of Dr. Petrou has received research support from Praxis Precision Medicines. Dr. Petrou has received intellectual property interests from a discovery or technology relating to health care. |
| Wildon Farwell, MD |
Dr. Farwell has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Farwell has received personal compensation for serving as an employee of Satellos Biosciences. Dr. Farwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Paragon Therapeutics. Dr. Farwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Farwell has stock in Dyne Therapeutics. Dr. Farwell has stock in Satellos Bioscience. |
| Catherine Parisien |
Ms. Parisien has nothing to disclose. |
| Eines Monteagudo, MD |
Mrs. Monteagudo has nothing to disclose. |
| Stan Crooke |
No disclosure on file
|
| Kaushik Patra, PhD |
Dr. Patra has received personal compensation for serving as an employee of Ultragenyx. Dr. Patra has stock in Ultragenyx. |
| Deepa S. Rajan, MD, FAAN |
Dr. Rajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Rajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Rajan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. The institution of Dr. Rajan has received research support from National Scleroderma Foundation. The institution of Dr. Rajan has received research support from Denali Therapeutics. The institution of Dr. Rajan has received research support from Ultragenyx . The institution of Dr. Rajan has received research support from Regenxbio. The institution of Dr. Rajan has received research support from Takeda. The institution of Dr. Rajan has received research support from Prevail Therapeutics. The institution of Dr. Rajan has received research support from Children's Neuroscience Institute. Dr. Rajan has received intellectual property interests from a discovery or technology relating to health care. |
| Stephen Kingsmore |
Stephen Kingsmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Third Rock Ventures. Stephen Kingsmore has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB2 Bio. Stephen Kingsmore has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Illumina. Stephen Kingsmore has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACMGG. Stephen Kingsmore has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Stephen Kingsmore has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Rady Children's Institute for Genomic Medicine. Stephen Kingsmore has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Sidra Medicine. Stephen Kingsmore has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Stephen Kingsmore has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cold Spring Harbor Press. Stephen Kingsmore has stock in Third Rock Ventures. The institution of Stephen Kingsmore has received research support from Alexion, Amgen, Biomarin, Chiesi, Inozyme, Ionis, Mahzi, Orchard, Sanofi, Rocket, Sarepta, Sentynyl, Travere, Ultragenyx. The institution of Stephen Kingsmore has received research support from NIH. Stephen Kingsmore has received intellectual property interests from a discovery or technology relating to health care. Stephen Kingsmore has received intellectual property interests from a discovery or technology relating to health care. |
| Brian Werneburg |
Mr. Werneburg has received personal compensation for serving as an employee of Stoke Therapeutics. |
| Erik Niks, MD, PhD |
Dr. Niks has nothing to disclose. |
| Barry S. Ticho, MD, PhD |
Dr. Ticho has received personal compensation for serving as an employee of Stoke Therapeutics. |
| Mireia del Toro, MD |
Dr. del Toro has nothing to disclose. |
| Mohammad Burhanuddin, MBBS |
Dr. Burhanuddin has nothing to disclose. |
| James Empfield, PhD |
Dr. Empfield has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Empfield has stock in Xenon Pharmaceuticals. |
| Federica Rizzo, PhD |
Dr. Rizzo has nothing to disclose. |
| Maegan Soriano, BSc |
Ms. Soriano has received personal compensation for serving as an employee of Xenon Pharmaceuticals . Ms. Soriano has stock in Xenon Pharmaceuticals . |
| Nourhan Hatem II, MD |
Dr. Hatem has nothing to disclose. |
| Kendall P. Robbins, BS |
Ms. Robbins has nothing to disclose. |
| Maria Fuller, PhD |
The institution of Prof. Fuller has received research support from Ultragenyx. The institution of Prof. Fuller has received research support from Paradigm. The institution of Prof. Fuller has received research support from Sanofi. |
| Harrison Clement, MS |
Mr. Clement has nothing to disclose. |
| Mohammed Sabri Hassanin, MD |
Dr. Hassanin has nothing to disclose. |
| Fei Wang, PhD |
Fei Wang, PhD has received personal compensation for serving as an employee of Stoke Therapeutics. |
| Mohamed A. Mostafa II, MBBS |
Dr. Mostafa has nothing to disclose. |
| Ubaid Ur Rehman, MBBS |
Dr. Rehman has nothing to disclose. |
| Salma Allam, MD |
Dr. Allam has nothing to disclose. |
| Vishaal Rajani, PhD |
Dr. Rajani has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Rajani has stock in Xenon Pharmaceuticals Inc.. |
| Amatul Aala, MBBS |
Miss Aala has nothing to disclose. |
| Linda Laux, MD |
Dr. Laux has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Laux has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. |
| Abdul Rafeh Awan, MBBS |
Dr. Awan has nothing to disclose. |
| Colin M. Roberts, MD |
Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. |
| Simona Lodato |
Simona Lodato has nothing to disclose. |
| María Luz Couce, MD, PhD |
Prof. Couce has nothing to disclose. |
| Sithara Ramdas, MD, MBBS |
Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pfizer. Dr. Ramdas has received personal compensation in the range of $0-$499 for serving as a Consultant for Italfarmaco. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Ramdas has received research support from Myaware . The institution of Dr. Ramdas has received research support from Norman Collison Foundation. . |
| Zainab A. Memon, MBBS |
Dr. Memon has nothing to disclose. |
| Nigel Colenbier, PhD |
Mr. Colenbier has received personal compensation for serving as an employee of clouds of care. |
| Emily Hurley |
Ms. Hurley has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. |
| Kelly G. Knupp, MD |
The institution of Dr. Knupp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Knupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research. |
| Juliette Giacobbe, PhD |
Dr. Giacobbe has received personal compensation for serving as an employee of argenx. Dr. Giacobbe has stock in argenx. |
| He Pu, PhD |
Dr. Pu has received personal compensation for serving as an employee of n-Lorem Foundation. |
| Zonaira Mushahid, MBBS |
Dr. Mushahid has nothing to disclose. |
| Liana Protopsaltis, MS, CGC |
Mrs. Protopsaltis has nothing to disclose. |
| J.P Johnson Jr, PhD |
Dr. Johnson Jr has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Johnson Jr has stock in Xenon Pharmaceuticals. Dr. Johnson Jr has received intellectual property interests from a discovery or technology relating to health care. |
| Sami Asif |
Mr. Asif has nothing to disclose. |
| Francesca Beatrice |
Francesca Beatrice has nothing to disclose. |
| Pam Ventola, PhD |
Dr. Ventola has received personal compensation for serving as an employee of Cogstate. The institution of Dr. Ventola has received research support from NIH. |
| Courtney Wells |
Ms. Wells has received personal compensation for serving as an employee of Satellos Bioscience, Inc.. Ms. Wells has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for HSG. Ms. Wells has stock in Satellos Bioscience, Inc.. Ms. Wells has stock in Tourmaline. |
| Pieter van Mierlo, PhD |
Prof. van Mierlo has received personal compensation for serving as an employee of Clouds of Care. Prof. van Mierlo has stock in Clouds of Care. |
| Joseph G. Gleeson, MD |
Prof. Gleeson has received personal compensation for serving as an employee of Ionis. Prof. Gleeson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. |
| Israa Abdeen, MBBS |
Dr. Abdeen has nothing to disclose. |
| Lucy Dougherty, MD |
Ms. Dougherty has nothing to disclose. |
| Steven Wesolowski, PhD |
Dr. Wesolowski has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Wesolowski has stock in Xenon Pharmaceuticals. Dr. Wesolowski has received intellectual property interests from a discovery or technology relating to health care. |
| Philip Lambert, PhD |
Dr. Lambert has received personal compensation for serving as an employee of Satellos Bioscience. Dr. Lambert has stock in Satellos Bioscience. Dr. Lambert has received intellectual property interests from a discovery or technology relating to health care. |
| Muneeb Ahmad Muneer |
Mr. Muneer has nothing to disclose. |
| Rania naqrashi, MBBS |
Miss naqrashi has nothing to disclose. |
| Velislava Zoteva, PhD |
Dr. Zoteva has received personal compensation for serving as an employee of Clouds of Care. |
| Kimberly A. Parkerson, MD, PhD |
Dr. Parkerson has received personal compensation for serving as an employee of Stoke Therapeutics. Dr. Parkerson has stock in Stoke Therapeutics. |
| Maja Filipovic, BSc |
Ms. Filipovic has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Ms. Filipovic has stock in Xenon Pharmaceuticals. |
| Andrea D'Angelo |
Andrea D'Angelo has nothing to disclose. |
| Elizabeth M. Berry-Kravis, MD, PhD |
The institution of Dr. Berry-Kravis has received research support from NIH. The institution of Dr. Berry-Kravis has received research support from Ionis. The institution of Dr. Berry-Kravis has received research support from Zynerba. The institution of Dr. Berry-Kravis has received research support from Roche. The institution of Dr. Berry-Kravis has received research support from CDC. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation. The institution of Dr. Berry-Kravis has received research support from GeneTx. The institution of Dr. Berry-Kravis has received research support from Angelman Syndrome Foundation. The institution of Dr. Berry-Kravis has received research support from Acadia. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Mallinckrodt. The institution of Dr. Berry-Kravis has received research support from Together Strong Foundation. The institution of Dr. Berry-Kravis has received research support from Zevra. The institution of Dr. Berry-Kravis has received research support from Taysha. The institution of Dr. Berry-Kravis has received research support from Tetra. The institution of Dr. Berry-Kravis has received research support from Neuren. |
| Elaine C. Wirrell, MD, FAAN |
Dr. Wirrell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN. Dr. Wirrell has received publishing royalties from a publication relating to health care. |
| Jung Yun Kim |
Mr. Kim has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Mr. Kim has stock in Xenon Pharmaceuticals. Mr. Kim has received publishing royalties from a publication relating to health care. |
| Jan Noukens |
The institution of Mr. Noukens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. |
| Flavia H. Menezes, MD |
Dr. Menezes has received personal compensation for serving as an employee of argenx. |
| Archana Desurkar, MD, MBBS, MRCPCH |
Dr. Desurkar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biocodex. Dr. Desurkar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for STOKE therapeutics. Dr. Desurkar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. |
| Long H. Tu, MD, PhD |
Dr. Tu has received publishing royalties from a publication relating to health care. |
| Verner A. Lofstrand, PhD |
Mr. Lofstrand has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Mr. Lofstrand has stock in Xenon Pharmaceuticals. Mr. Lofstrand has received intellectual property interests from a discovery or technology relating to health care. |
| Arjun Mahadevan, MSc |
Mr. Mahadevan has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Mr. Mahadevan has stock in Xenon Pharmaceuticals Inc. |
| Ahmed R. Harb |
Mr. Harb has nothing to disclose. |
| Kristen Truxal, MD |
The institution of Dr. Truxal has received research support from Ultragenyx. The institution of Dr. Truxal has received research support from Inozyme Therapeutics. |
| M. S. Perry, MD |
Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stoke therapeutics. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus. Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for jazz pharmaceuticals. Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pyros. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for azurity. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Dr. Perry has stock in Praxis Precision Medicine. Dr. Perry has stock in Biohaven. Dr. Perry has stock in Rapport. Dr. Perry has stock in Alto Neurosciences. Dr. Perry has a non-compensated relationship as a president with child neurology foundation that is relevant to AAN interests or activities. Dr. Perry has a non-compensated relationship as a President with Pediatric Epilepsy Research Consortium that is relevant to AAN interests or activities. |
| Anna Kostera-Pruszczyk |
Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneka. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. |
| SAI VENKATA MANOJ KOTHARU, MBBS |
Dr. KOTHARU has nothing to disclose. |
| Apeksha Pokalkar, MBBS |
Dr. Pokalkar has nothing to disclose. |
| Abdur Rehman, MBBS |
Dr. Rehman has nothing to disclose. |
| Zainab Awan, MBBS |
Miss Awan has nothing to disclose. |